Traditional flow cytometry faces significant limitations when analyzing fluorochromes with similar emission spectra, often forcing researchers to compromise on panel design and biomarker selection.

Additionally, the multicolor unmixing capabilities of NovoCyte Opteon were validated using multiple fluorochrome combinations excited by the additional 405, 561, or 637 nm lasers. In summary, spectral ...

In a move that underscores its dedication to shaping the future of cell analysis, Cytek Biosciences, Inc. announced the launch of the Cytek Aurora Evo system, a new full spectrum flow cytometer that ...

Cytek Biosciences unveils Cytek Aurora Evo system; setting new standard for full spectrum flow cytometry Fremount, California Saturday, May 31, 2025, 15:00 Hrs [IST] In a move that underscores its ...

Per a Research report, the flow cytometry market was valued at $4.68 billion in 2024 and is expected to witness a compound annual growth rate of 8.4% through 2030.

Industry Prospects Favoring Thermo Fisher Per a Research report, the flow cytometry market was valued at $4.68 billion in 2024 and is expected to witness a compound annual growth rate of 8.4% through ...

Cytek today unveiled the Cytek Aurora™ Evo system, a full spectrum flow cytometer that builds on the trusted performance of the Cytek Aurora system. Designed to set a new standard in spectral flow ...

First launched in 2017 to address the limitations of existing flow cytometry technologies, Cytek’s Full Spectrum Profiling™ (FSP®) systems have become the spectral technology of choice for ...

Thermo Fisher Scientific Launches New Spectral Flow Cytometer Offering Increased Speed, Versatility and Reliability to Labs Researchers can obtain deeper insights from cells with more colors and ...

According to Vantage Market Research, the Global Flow Cytometry Market is estimated to be valued at USD 14 Billion by 2035 at an exponential growth of 9.65% in the next seven years. The increasing ...